•  
  •  
  •  
  •  

2025-10-02 03:37:00

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  NACLIndustries

Stock Report

  • NACL Industries Ltd Q1FY26 consolidated profit at Rs. 13.04 crores
  • NACL Industries Ltd consolidated Q2FY25 PAT zooms to Rs. 14.90 crores
  • NACL Agri-Solutions Pvt Ltd, NACL Multichem Pvt Ltd commence commercial production
  • NACL Industries Ltd consolidated Q3 FY24 loss at Rs. 15.90 crores
  • NACL Industries Limited to foray into Specialty Chemicals, Advanced Intermediates, Specialty Nutrition and Bioproducts
  • NACL Industries Ltd Q1 FY2023-24 consolidated loss at Rs. 38.06 crores
  • NACL Industries Limited announces revenue growth of 30% for FY 2023-24
  • NACL Multichem Pvt Ltd granted Environment Clearance for new project
  • NACL Industries Ltd declares 2nd interim dividend of Rs. 0.15
  • NACL Industries Ltd consolidated Q3FY23 profit at Rs. 16.53 crores
  • NACL Spec-Chem Ltd commences commercial operations of greenfield project
  • NACL Industries Limited declares 1st interim dividend of Rs. 0.30
  • NACL Industries Ltd Q2 FY23 consolidated profit at Rs. 29.89 crores
  • NACL Industries Ltd Q1 FY23 consolidated PAT at Rs. 14.92 crores
  • NACL Industries Ltd Board recommends Final Dividend of Rs. 0.15
  • NACL Industries posts Rs. 20.38 crores consolidated profit in Q4FY22
  • NACL Industries Limited gets Environment Clearance for expansion
  • NACL Industries Ltd Board declares Third Interim Dividend of Rs. 0.15
  • NACL Industries consolidated Q3 PAT at Rs. 14.41 crores in FY22
  • NACL Industries Ltd consolidated Q2 FY2021-22 net profit up at Rs. 24.38 crore

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024